This provider's $10.1M in total Medicare payments ranks in the 99th percentile of Interventional Pain Management providers nationally.
Medicare payments to this provider grew 78% from 2014 to 2023.
68% of their billing comes from a single procedure code (G0483 — Drug test def 22+ classes).
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $449.44 | $51.69 | 8.69x | $397.75 | $572.2K | 20.9K | 8.1K |
| 2015 | $485.52 | $48.12 | 10.09x | $437.40 | $828.2K | 34.3K | 13.4K |
| 2016 | $756.79 | $81.87 | 9.24x | $674.92 | $946.0K | 5.8K | 3.0K |
| 2017 | $851.97 | $81.43 | 10.46x | $770.54 | $1.3M | 6.7K | 2.9K |
| 2018 | $732.39 | $73.32 | 9.99x | $659.07 | $1.3M | 6.7K | 3.0K |
| 2019 | $701.43 | $67.31 | 10.42x | $634.12 | $879.5K | 4.5K | 2.5K |
| 2020 | $758.37 | $99.70 | 7.61x | $658.67 | $1.3M | 5.6K | 2.4K |
| 2021 | $619.75 | $93.54 | 6.63x | $526.21 | $1.2M | 5.5K | 2.3K |
| 2022 | $690.06 | $118.91 | 5.80x | $571.15 | $804.5K | 8.5K | 3.8K |
| 2023 | $605.40 | $86.24 | 7.02x | $519.16 | $1.0M | 12.0K | 5.3K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0483 | Drug test def 22+ classes | 27.1K | $6.4M | $236.51 | 2.66x |
| G0480 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an | 9.8K | $1.1M | $110.43 | 2.17x |
| 80307 | Testing for presence of drug | 10.7K | $634.4K | $59.12 | 3.89x |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | 5.2K | $373.9K | $71.30 | 2.45x |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | 589 | $86.1K | $146.21 | 2.05x |
| G6046 | Dihydromorphinone | 2.4K | $78.7K | $33.42 | 1.02x |
| 72148 | MRI scan of lower spinal canal | 803 | $77.8K | $96.88 | 12.05x |
| G6055 | Nicotine | 2.4K | $73.4K | $31.18 | 1.10x |
| G6045 | Dihydrocodeinone | 2.4K | $64.8K | $27.50 | 1.09x |
| G6051 | Flurazepam | 2.4K | $62.1K | $26.36 | 1.14x |
| G6056 | Opiate(s), drug and metabolites, each procedure | 2.4K | $60.9K | $25.91 | 1.16x |
| G6031 | Benzodiazepines | 2.4K | $58.4K | $24.57 | 1.22x |
| 63650 | Implantation of spinal neurostimulator electrodes, accessed through the skin | 244 | $56.5K | $231.53 | 24.73x |
| G6030 | Amitriptyline | 2.4K | $56.1K | $23.83 | 1.26x |
| G6052 | Meprobamate | 2.4K | $55.3K | $23.47 | 1.28x |
| G6053 | Methadone | 2.4K | $51.5K | $21.65 | 1.39x |
| G6037 | Nortriptyline | 2.4K | $42.5K | $18.04 | 1.66x |
| 83925 | Opiates (drug) measurement | 1.7K | $42.0K | $24.09 | 1.04x |
| 80154 | Benzodiazepines level | 1.7K | $42.0K | $24.07 | 1.04x |
| G6058 | Drug confirmation, each procedure | 2.4K | $41.9K | $17.64 | 1.70x |
This provider submits charges 2.91 times higher than what Medicare actually pays.
A markup ratio of 2.91x means for every $100 Medicare pays, this provider initially charges $291. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data